Neurofeedback insurance coverage in Arizona: Anthem's 2026 policy excludes all indications. Learn appeal options, costs, and alternative funding pathways.
If you recently scheduled neurofeedback therapy or have been considering it for ADHD, PTSD, or a traumatic brain injury, a major insurance policy change may directly affect what you pay out of pocket. Anthem Blue Cross has officially reclassified EEG neurofeedback as "not medically necessary for all indications," effective July 1, 2026. For Arizona patients, this shift raises an urgent and practical question: is neurofeedback covered by insurance at all anymore?
The short answer is complicated, and that is exactly why this guide exists. Understanding what the new policy covers, what it excludes, and what your real options are can mean the difference between getting the care you need and walking away from treatment altogether. In the sections below, you will learn precisely what Anthem's clinical guideline CG-MED-97 says, how other Arizona insurers approach neurofeedback coverage, what out-of-pocket costs to expect, and which financing pathways, including attorney liens for injury-related cases, may make treatment accessible regardless of your coverage status. No qualified patient should rule out care before reviewing every available option.
What Just Changed and Why Arizona Patients Are Affected
On July 1, 2026, Anthem Blue Cross activated clinical guideline CG-MED-97, reclassifying EEG neurofeedback as "not medically necessary for all indications." That phrase, "all indications," is the critical detail: not one diagnosis, no matter how well-documented, qualifies for coverage under this rule. ADHD, PTSD, traumatic brain injury, anxiety, and autism spectrum disorders are all explicitly excluded.
The policy applies to Arizona residents enrolled in Anthem individual plans, employer-sponsored plans, and marketplace plans. Patients who were already mid-treatment when July 1 arrived faced an immediate reimbursement cliff, with little guidance from Anthem on how to manage the transition or whether any continuity provisions applied.
The confusion is understandable, but one distinction matters above everything else: "not medically necessary" is an insurance coverage determination, not a clinical one. Anthem's own guideline acknowledges that neurofeedback is actively being studied for a range of medical and psychological conditions. The policy does not declare the therapy unsafe or ineffective; it declares that Anthem will not pay for it. Those are different statements with very different implications for patients weighing their options.
For anyone seeking to understand whether neurofeedback is appropriate for their specific situation, the question of safety and candidacy is entirely separate from the insurance question. You can review what the clinical evidence says about who is a good candidate for neurofeedback and what the research shows about its safety profile independently of what Anthem's policy says.
Understanding the exact scope of this exclusion is the necessary first step. From there, viable paths forward do exist, including formal appeals, alternative financing, and attorney liens for patients with personal injury claims, all covered in the sections that follow.
What Anthem's Policy CG-MED-97 Actually Says
CG-MED-97 is Anthem's clinical guideline covering both traditional biofeedback and EEG neurofeedback. The two are not the same modality, and the policy treats them very differently. Understanding that distinction is the key to reading your Explanation of Benefits correctly and knowing what, if anything, can be appealed.
Zero Approved Indications for EEG Neurofeedback
Neurofeedback, as defined by CG-MED-97, is EEG-based biofeedback: sensors read brainwave activity, and that information is fed back to the patient, typically through audio or video, to train self-regulation of brain function. If you want to understand the clinical process behind this in plain language, this guide to neurofeedback and brain mapping walks through it step by step.
Under the revised guideline, effective July 1, 2026, Anthem classifies EEG neurofeedback as "not medically necessary for all indications." That phrase matters precisely because of the word "all." There is no diagnosis, no severity level, and no volume of supporting documentation that unlocks coverage. The policy names ADHD, PTSD, traumatic brain injury, autism spectrum disorders, and substance use disorders as explicitly excluded conditions. These are not edge cases; they represent the majority of patients who actually seek neurofeedback therapy.
Home-based neurofeedback devices are excluded under the same guideline. Patients who hoped to use a direct-to-consumer or remote device and seek reimbursement will find that pathway closed as well.
What Anthem Still Covers: Traditional Biofeedback
The guideline does not eliminate biofeedback coverage entirely. Traditional biofeedback, which uses EMG sensors to measure muscle tension or thermal sensors to measure skin temperature, remains covered for seven specific conditions: cancer pain, chronic back pain as part of rehabilitation, chronic constipation, fecal incontinence, levator ani syndrome, migraines and tension headaches, and urinary incontinence.
This distinction carries a practical documentation consequence. Because both services may appear under biofeedback billing codes, providers and patients must ensure records clearly specify whether a session involved EMG-based or thermal biofeedback versus EEG neurofeedback. Ambiguous documentation increases the risk of denial even for covered services.
What Happens to Your Claim
When a claim for EEG neurofeedback is submitted under an Anthem plan, it is denied at the payer level as not medically necessary. It does not reach a clinician for individual review. The denial is automatic and policy-driven, not a judgment about your specific case or diagnosis history.
Does This Apply to You? Navigating Arizona's Insurance Landscape
CG-MED-97 applies specifically to Anthem Blue Cross members. If your card carries a different insurer's name, that policy does not govern your plan.
Arizona's insurance market includes multiple major carriers, and neurofeedback coverage varies considerably across them. Some plans classify neurofeedback as investigational and evaluate it case by case. Others issue categorical exclusions similar to Anthem's. A few may still provide limited coverage for specific diagnoses. There is no single industry-wide standard, which means your neighbor's experience with their plan tells you nothing reliable about yours.
If you have an employer-sponsored plan, request your Summary Plan Description (SPD) from HR or your benefits administrator. The SPD is the governing document that specifies which medical policies your plan follows. Ask directly whether the plan applies Anthem's CG-MED-97 or uses a separate behavioral health medical policy. Self-funded employer plans, which are common among larger companies, sometimes operate under entirely different coverage rules than commercial marketplace plans.
If you are enrolled in a Medicare Advantage plan in Arizona, do not assume your coverage mirrors traditional Medicare. Medicare Advantage plans set their own coverage policies within federal guidelines, and neurofeedback determinations vary by plan. Call the member services number on your insurance card and ask specifically about coverage for CPT codes 90875 and 90876, the billing codes used for biofeedback procedures. Getting that answer in writing, or at minimum noting the representative's name and the date of the call, protects you later.
If you are covered by Arizona Medicaid (AHCCCS) or a regional carrier, contact your plan directly before assuming Anthem's exclusion applies.
The core takeaway: verify your specific plan before scheduling. You can review payment and coverage options at Neuron Connect's Pay with Medical Insurance page as a starting point, then confirm directly with your insurer.
Why Insurers Are Calling Neurofeedback 'Not Medically Necessary'
Once you know which insurer is excluding neurofeedback, the next logical question is why. Understanding the reasoning behind that label makes it far less intimidating.
"Not medically necessary" is an administrative determination, not a clinical verdict. When Anthem attaches this label to neurofeedback under CG-MED-97, it is communicating that the treatment does not yet meet the insurer's internal coverage criteria. It says nothing about whether the treatment is safe, harmful, or ineffective for a specific patient.
How Insurers Define "Medical Necessity"
Insurers typically require a treatment to clear three thresholds before granting covered status:
FDA approval of the procedure itself (device clearance alone does not qualify)
Inclusion in peer-reviewed clinical guidelines from recognized medical bodies
Demonstrated superiority or equivalence to already-covered alternatives
Neurofeedback faces documented gaps on all three fronts, despite a growing body of supportive research. The procedure itself is not FDA-approved, even though the EEG hardware used in sessions carries FDA clearance. Clinical guidelines from major bodies have not yet formally endorsed neurofeedback for the conditions it most commonly addresses.
The MCG guideline revised July 15, 2026 illustrates this distinction precisely. It endorses traditional EMG and thermal biofeedback for migraines and tension headaches, citing American Academy of Neurology guidance. It stops at that line and does not extend support to EEG neurofeedback for any indication. For insurers, that boundary is meaningful.
The Shift Toward Categorical Exclusions
Anthem's 2026 revision reflects a broader cost-containment trend. Rather than reviewing neurofeedback condition by condition, the policy issues a single blanket exclusion covering all indications. This consolidates claims administration and eliminates case-by-case appeals at the utilization review stage. It is a financial efficiency decision as much as an evidence-based one.
This pattern is not unique to neurofeedback. Treatments now recognized as standard of care have passed through similar exclusion windows before accumulating enough guideline endorsements to qualify for coverage. The gap between clinical practice and insurance policy is a known feature of emerging therapies, not evidence that a treatment lacks value.
For patients, this framing matters practically. A denial is the starting point for an appeal or a conversation about alternative funding, not a final word on whether neurofeedback is appropriate for your situation. Knowing what to look for in a mental health clinic that can document and support your case is a meaningful first step toward navigating what comes next.
How Much Does Neurofeedback Therapy Cost Without Insurance?
So what does navigating neurofeedback without insurance actually cost? Understanding the numbers up front prevents the financial uncertainty that causes many patients to never book at all.
Out-of-pocket treatment in Arizona typically starts with a qEEG brain mapping session. This is a one-time diagnostic step that records your brainwave activity, identifies irregular patterns, and informs a personalized treatment protocol. It is priced separately from your ongoing sessions, so expect two distinct line items from the start.
Individual neurofeedback sessions generally run $100 to $250 per session, depending on the provider, session length, and whether your protocol is guided by a licensed clinician or supported by a technician. Clinician-directed care carries a higher per-session cost and also delivers more precise protocol adjustments over time.
The total investment depends heavily on session count. Most protocols require 20 to 40 sessions to produce durable results for conditions like ADHD, PTSD, or post-concussion symptoms. At $100 to $250 per session, that puts the realistic total cost range at roughly $2,000 to $10,000. For guidance on how session numbers are typically determined, see how many neurofeedback sessions are needed based on diagnosis and treatment goals.
Frequency shapes how that cost lands on your calendar. Most active treatment protocols call for two to three sessions per week, which compresses the full course into a two-to-four month window rather than distributing expense across a full year. For many patients, a shorter, intensive timeline is actually easier to finance than an open-ended commitment.
When requesting a cost estimate, ask your provider to break it into three components: the qEEG mapping fee, the per-session rate, and any protocol design or mid-course reassessment fees. That itemized structure makes it significantly easier to plan for financing, use HSA or FSA funds, or structure a lien agreement if your treatment stems from a personal injury.
At Neuron Connect, pricing is transparent and session count estimates are discussed during the intake consultation, so patients know what to expect before committing to a plan.
Your Options When Insurance Won't Cover Neurofeedback Therapy
Knowing the likely cost range is only half the equation. The other half is figuring out how to cover it when your insurer won't.
Self-pay is the most direct route. You pay per session or purchase a package of sessions at a discounted rate, and no prior authorization, referral, or insurer approval is required. You control the schedule and the pace.
HSA and FSA funds are a practical option many patients overlook. If a licensed medical provider prescribes or recommends neurofeedback as part of your treatment plan, you can generally use Health Savings Account or Flexible Spending Account dollars to pay for it. Because those accounts are funded with pre-tax dollars, you effectively reduce the real cost of every session. The IRS defines qualified medical expenses broadly enough to include treatments recommended by a licensed provider; confirm eligibility with your plan administrator before your first session.
Medical financing lets you spread the total treatment investment across monthly payments, often with a promotional zero-interest period. This is particularly useful if you need to begin treatment now but cannot absorb the full cost upfront. Several third-party lenders specialize in healthcare financing and can provide a decision quickly.
Sliding-scale pricing is less widely advertised but worth asking about. Some clinics reduce fees for patients who demonstrate financial hardship. The only way to know whether that flexibility exists is to ask directly during the intake conversation.
Attorney liens are a separate pathway entirely, designed specifically for patients whose need for neurofeedback stems from a personal injury, car accident, or workplace injury. A lien allows treatment to begin immediately with no upfront payment; the clinic collects from your settlement when the case resolves. Because this pathway has its own mechanics and eligibility considerations, it gets a dedicated explanation in the next section. You can also find an overview of cost, insurance, and the attorney-lien option on the Neuron Connect site.
Neuron Connect accepts self-pay, HSA and FSA payments, financing, and attorney liens, because a coverage denial should not be the reason a qualified patient never starts treatment.
The Attorney Lien Pathway: A Funding Option for Injury-Related Cases
Of all the payment options available when insurance won't cover neurofeedback, the attorney lien pathway is the most specialized, and the most underused by patients who qualify for it.
A medical lien (also called an attorney lien) is a formal agreement under which a healthcare provider delivers treatment now and collects payment later, directly from the patient's personal injury settlement or court verdict. The patient owes nothing out of pocket while treatment is ongoing. Arizona law establishes this arrangement under A.R.S. §§ 33-931 through 33-936, giving licensed providers a statutory right to place a lien against third-party settlements for the value of services rendered.
This pathway applies specifically to patients who were injured and have an active personal injury claim, including car accidents, slip-and-fall incidents, and workplace injuries. Those are precisely the scenarios most likely to produce TBI, concussion, and PTSD, the conditions where neurofeedback is most clinically relevant and where Anthem's 2026 exclusion creates the sharpest access problem.
How the mechanics work: the patient's attorney signs a lien agreement directly with the clinic. Treatment begins immediately. When the case settles, the clinic receives payment from settlement proceeds before the remainder is distributed to the patient. No credit check is run. No monthly payment is scheduled. The financial barrier is removed at every stage of treatment.
Critically, patients do not need to wait for a settlement to start care. For TBI and concussion recovery, early intervention matters clinically. The lien structure is designed to eliminate the timing conflict between slow-moving legal timelines and time-sensitive medical needs.
Neuron Connect is attorney-lien friendly and coordinates directly with personal injury attorneys across Arizona. For a closer look at how this works for injury patients specifically, this overview of attorney-lien friendly neurofeedback for injury victims seeking cognitive recovery explains the process in detail. Patients with active claims should raise this at intake so lien paperwork can be initiated before the first session, not after.
If your insurer has already denied neurofeedback coverage and you have an open personal injury case, a lien arrangement may allow you to begin treatment this week.
Can You Appeal Anthem's Neurofeedback Denial?
For patients whose situation does not fit the lien pathway, an appeal is worth pursuing rather than abandoning.
Anthem members have federally protected appeal rights under the Affordable Care Act, codified at 45 CFR § 147.136, regardless of whether coverage was denied for neurofeedback, PTSD treatment, or any other service. Arizona state insurance regulations reinforce those rights. A denial letter is not a final verdict; it is the opening of a formal process.
What a Strong Appeal Requires
Three elements carry the most weight with Anthem reviewers:
A letter of medical necessity from your treating provider explaining why neurofeedback is clinically appropriate for your specific diagnosis
Peer-reviewed clinical literature linking neurofeedback to your condition, such as ADHD, PTSD, or post-concussion symptoms
Documentation that covered alternatives were tried and failed or are contraindicated for you specifically
That third point matters because it shifts the argument from "this treatment is valid" to "this treatment is necessary for this patient."
Know What You Are Up Against
Under Arizona law, Anthem must provide a written explanation of every denial and must offer both an internal appeal and an independent external review. If the internal appeal is denied, you have the right to escalate to that external review.
However, CG-MED-97 is a blanket categorical exclusion, not a case-by-case utilization decision. Appealing a categorical policy is meaningfully harder than appealing a single-patient denial, because there are no approved indications within the policy to point toward. Success rates are lower. Do not delay starting treatment while waiting for an appeal outcome; the process can take weeks or months.
The Documentation Has Value Beyond the Appeal
Even an unsuccessful appeal generates records that serve other purposes. Letters of medical necessity, diagnosis history, and clinical records support HSA and FSA eligibility verification and simplify lien paperwork if that pathway applies to your situation. The measurable neurological basis for conditions like depression illustrates why clinical documentation is increasingly important across brain-based therapies.
Neuron Connect's clinical team can help generate the records and documentation that support an appeal. For the formal submission itself, work with your own attorney or a patient advocate.
How to Get Started with Neurofeedback Therapy at Neuron Connect
Whether your appeal is still in progress or you've already received a final denial, there is no reason to wait before exploring whether treatment is within reach.
Getting started at Neuron Connect begins with an initial consultation. The clinical team uses that conversation to understand your primary concerns, relevant diagnosis history, and what you hope to achieve through treatment. Payment options are addressed at this stage as well, including self-pay rates, HSA and FSA funds, third-party financing, and attorney liens for patients with active personal injury cases. Nothing is left to surface later as a billing surprise.
A qEEG brain mapping session follows the consultation. Quantitative EEG, or qEEG, records electrical activity across regions of the brain and produces a data-driven profile of how your brain is currently functioning. This step identifies which brainwave patterns are driving your specific symptoms, whether that is attention difficulty, anxiety, emotional dysregulation, or post-concussion cognitive fog. It is a diagnostic foundation, not a formality.
The qEEG findings then shape a personalized neurofeedback protocol. Session frequency, duration, and the brain regions targeted are all determined by your individual data rather than a generic template. This individualized approach is especially important for patients presenting with overlapping conditions such as TBI and PTSD, where a one-size-fits-all protocol is unlikely to be sufficient.
Neuron Connect sees patients in Phoenix, Scottsdale, and Tucson. The clinical team has direct experience with personal injury cases, veterans, first responders, and patients who have not responded adequately to medication.
If your insurer has told you neurofeedback is not covered, contact the clinic before assuming treatment is out of reach. The payment flexibility described throughout this piece exists specifically for patients in that position.
Frequently Asked Questions About Neurofeedback Insurance Coverage
Does insurance cover neurofeedback therapy in Arizona?
As of July 1, 2026, Anthem Blue Cross covers zero neurofeedback indications under policy CG-MED-97. Coverage under other Arizona carriers varies; each insurer must be verified individually before assuming the same exclusion applies to your plan.
Is neurofeedback covered for ADHD or PTSD?
Anthem explicitly names both conditions in its exclusion list. If you carry a different insurer, ask your plan administrator specifically about behavioral health neurofeedback CPT codes 90875 and 90876 rather than asking about "neurofeedback" generically.
How much does neurofeedback therapy cost in Arizona without insurance?
Individual sessions typically run $100 to $250. Most treatment protocols require 20 to 40 sessions, placing the total out-of-pocket investment between roughly $2,000 and $10,000 depending on session count and per-session rate.
What is the difference between biofeedback and neurofeedback for insurance purposes?
Traditional EMG and thermal biofeedback remain covered by Anthem for seven specific conditions, including migraines and chronic back pain. EEG-based neurofeedback is entirely excluded. When submitting claims or discussing treatment with a provider, the distinction in documentation matters; the same insurer that approves one will deny the other.
Can I use my HSA or FSA for neurofeedback?
Generally yes. HSA and FSA funds can be applied to neurofeedback when a licensed provider recommends it as part of a documented treatment plan. Eligibility is governed by your specific plan and IRS rules, not by your insurer's coverage policy, so confirm with your plan administrator before paying.
What should I do if I need neurofeedback therapy near me but cannot afford out-of-pocket costs?
Contact Neuron Connect directly. The clinic offers self-pay rates, session packages, financing options, and attorney lien arrangements for injury-related cases. An insurance denial is a coverage decision, not a final answer on access; a conversation with the intake team is the fastest way to find a workable path forward.
What Arizona Patients Should Do Next
The answers in the FAQ above clarify what the policy says. What follows is what you should actually do with that information.
First, confirm whether CG-MED-97 even applies to your plan. Anthem's exclusion is real, but it is not universal. Other Arizona carriers, employer-sponsored plans, and Medicare Advantage programs each maintain separate neurofeedback policies. Call member services, ask for your plan's medical policy on CPT codes 90875 and 90876, and get the answer in writing before assuming you have no coverage.
Second, treat a denial as a starting point, not a verdict. Arizona law gives you the right to an internal appeal and an independent external review. HSA and FSA funds can offset out-of-pocket costs when a licensed provider recommends treatment. Medical financing spreads remaining costs into monthly payments. Each of these pathways exists precisely because insurance denials are common and not always the final word.
Third, if your condition traces back to a car accident, workplace injury, or other personal injury event, act quickly. A lien arrangement lets treatment begin now, with payment collected from your settlement later. For TBI and concussion patients, timing matters clinically; postponing neurofeedback while a legal case moves through the system is not a neutral choice. Contact Neuron Connect to start the lien conversation before a delay becomes a clinical setback.
Fourth, schedule a consultation before making any financing decision. A clear protocol estimate, including session count and total cost, gives you the information you need to compare financing options realistically. Patients who know what they are committing to make better decisions and encounter fewer surprises.
Anthem's policy change is significant. It is not, however, an insurmountable obstacle. With the right documentation, the right payment pathway, and a clinical partner experienced in navigating exactly this situation, qualified patients can still access neurofeedback therapy in Arizona. Neuron Connect is built to help you find that path.
Conclusion
Anthem's policy change created a real barrier, but not an impossible one. Insurance denials are common, frequently contestable, and rarely the end of the road. Appeals, HSA and FSA funds, medical financing, and attorney lien arrangements all exist as legitimate pathways to care. For injury-related cases especially, acting quickly protects both your legal options and your clinical outcomes.
Neurofeedback therapy has real evidence behind it. Patients with ADHD, TBI, anxiety, and PTSD deserve access to treatments that work, regardless of what an insurer's blanket policy says.
Do not let a denial letter make the decision for you. Contact Neuron Connect today, get a clear protocol estimate, and learn which funding pathway fits your situation. The right support is available. The next step is simply to take it.